Acupuncture as Palliative Therapy for Physical Symptoms and Quality of Life for Advanced Cancer Patients

Abstract

Background. Acupuncture is underutilized as an adjunct cancer therapy. The main study objectives were to determine the feasibility of administering acupuncture as palliative therapy to patients with advanced ovarian or breast cancer and to assess the effect on symptoms and quality of life (QOL). Methods. This study was a pilot, single-armed prospective clinical trial for patients with advanced cancer to receive 12 acupuncture sessions over 8 weeks with follow-up at weeks 9 and 12. Ambulatory patients with advanced ovarian or breast cancer were enrolled to receive treatments at an outpatient academic oncology center. Symptom severity was measured before and after each acupuncture session. A composite QOL assessment tool, consisting of validated instruments, was completed at 5 time points. Results. Forty patients enrolled in the study. Twenty-eight patients (70%; 95% confidence interval [CI] = 53%-83%) completed 4 weeks of treatment, and 26 patients (65%; 95% CI = 48%-79%) completed 8 weeks. Eight patients (20%) withdrew before receiving acupuncture, and 6 patients (15%) discontinued treatment early because of disease progression or scheduling demands. Among all 32 assessed patients, there was self-reported improvement immediately post-treatment in anxiety, fatigue, pain, and depression and significant improvement over time for patients with anxiety (P = .001) and depression (P = .02). Among patients experiencing baseline symptoms, there was improvement in anxiety (P = .001), fatigue (P = .0002), pain (P = .0002), and depression (P = .003). QOL measures of pain severity and interference, physical and psychological distress, life satisfaction, and mood states showed improved scores during treatment, with sustained benefit at 12 weeks. Conclusions. This pilot study demonstrates that an 8-week outpatient acupuncture course is feasible for advanced cancer patients and produces a measurable benefit that should be evaluated in controlled trials.

Keywords

acupuncture palliative care symptom management ovarian cancer breast cancer

References

Jemal A. , Siegel R. , Ward E. , Hao Y. , Xu J. , Thun MJ Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225-249.

Cannistra SA Cancer of the ovary. N Engl J Med. 2004;351: 2519-2529.

du Bois A. , Quinn M. , Thigpen T. , Vermorken J. , Avall-Lundqvist E. , Bookman M. , et al., 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecological Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004). Ann Oncol. 2005;16(suppl 8):viii7-viii12.

de Haes J. , van Knippenberg F. , Neijt J. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer . 1990;62:1034-1038.

Penson RT , Wenzel LB , Vergote I. , Cella D. Quality of life considerations in gynecologic cancer: FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006;95(suppl 1):S247-S257.

Vickers A. , Straus D. , Fearon B. , Cassileth B. Acupuncture for postchemotherapy fatigue: a phase II study. J Clin Oncol. 2004;22:1731-1735.

Alimi D. , Rubino C. , Pichard-Léandri E. , Fermand-Brulé S. , Dubreuil-Lemaire ML , Hill C. Analgesic effect of auricular acupuncture for cancer pain: a randomized, blinded, controlled trial. J Clin Oncol. 2003;21:4120-4126.

Vickers A. , Cassileth B. Unconventional therapies for cancer and cancer-related symptoms. Lancet Oncol. 2001;2:226-232.

Shen J. , Wenger N. , Glaspy J. , et al. Electroacupuncture for control of myeloablative chemotherapy-induced emesis: a randomized controlled trial. JAMA. 2000;284:2755-2761.

10.

Yates JS , Mustian KM , Morrow GR , et al. Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Care Cancer. 2005;13:806-811.

11.

Armstrong T. , Cohen MZ , Hess KR , et al. Complementary and alternative medicine use and quality of life in patients with primary brain tumors. J Pain Symptom Manage. 2006;32: 148-154.

12.

Gansler T. , Kaw C. , Crammer C. , Smith T. A population-based study of prevalence of complementary methods use by cancer survivors: a report from the American Cancer Society’s studies of cancer survivors. Cancer. 2008;113:1048-1057.

13.

Mao JJ , Farrar JT , Xie SX , Bowman MA , Armstrong K. Use of complementary and alternative medicine and prayer among a national sample of cancer survivors compared to other populations without cancer. Complement Ther Med. 2007;15:21-29.

14.

Wahner-Roedler DL , Vincent A. , Elkin PL , Loehrer LL , Cha SS , Bauer BA Physicians’ attitudes toward complementary and alternative medicine and their knowledge of specific therapies: a survey at an academic medical center. Evid Based Complement Alternat Med. 2006;3:495-501.

15.

Milden SP , Stokols D. Physicians’ attitudes and practices regarding complementary and alternative medicine. Behav Med. 2004;30:73-82.

16.

Weiger WA , Smith M. , Boon H. , Richardson MA , Kaptchuk TJ , Eisenberg DM Advising patients who seek complementary and alternative medical therapies for cancer. Ann Intern Med. 2002;137(11):889-903.

17.

Tasaki K. , Maskarinec G. , Shumay DM , Tatsumura Y. , Kakai H. Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients’ perspectives. Psychooncology. 2002;11:212-220.

18.

Lu W. , Dean-Clower E. , Doherty-Gilman A. , Rosenthal D. The value of acupuncture in cancer care. Hematol Oncol Clin North Am. 2008;22:631-648, viii.

19.

Sagar SM Acupuncture as an evidence-based option for symptom control in cancer patients . Curr Treat Options Oncol. 2008;9:117-126.

20.

Lafferty WE , Bellas A. , Corage Baden A. , Tyree PT , Standish LJ , Patterson R. The use of complementary and alternative medical providers by insured cancer patients in Washington State. Cancer. 2004 ;100:1522-1530.

21.

Cui Y. , Shu XO , Gao Y. , et al. Use of complementary and alternative medicine by Chinese women with breast cancer. Breast Cancer Res Treat. 2004;85:263-270.

22.

Morris KT , Johnson N. , Homer L. , Walts D. A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. Am J Surg. 2000;179:407-411.

23.

MacPherson H. , Thomas K. , Walters S. , Fitter M. The York acupuncture safety study: prospective survey of 34,000 treatments by traditional acupuncturists. BMJ. 2001;323:486-487.

24.

NIH Consensus Conference. Acupuncture. JAMA . 1998;280: 1518-1524.

25.

Ezzo JM , Richardson MA , Vickers A. , et al. Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting. Cochrane Database Syst Rev. 2006 ;(2):CD002285.

26.

Molassiotis A. , Fernandez-Ortega P. , Pud D. , et al. Complementary and alternative medicine use in colorectal cancer patients in seven European countries. Complement Ther Med. 2005;13:251-257.

27.

Wang SM , Gaal D. , Maranets I. , Caldwell-Andrews A. , Kain ZN Acupressure and preoperative parental anxiety: a pilot study. Anesth Analg. 2005;101:666-669, table of contents.

28.

Nedstrand E. , Wyon Y. , Hammar M. , Wijma K. Psychological well-being improves in women with breast cancer after treatment with applied relaxation or electro-acupuncture for vasomotor symptom. J Psychosom Obstet Gynaecol. 2006; 27:193-199.

29.

Gejervall AL , Stener-Victorin E. , Möller A. , Janson PO , Werner C. , Bergh C. Electro-acupuncture versus conventional analgesia: a comparison of pain levels during oocyte aspiration and patients’ experiences of well-being after surgery. Hum Reprod. 2005 ;20:728-735.

30.

Standish LJ , Kozak L. , Congdon S. Acupuncture is underutilized in hospice and palliative medicine. Am J Hosp Palliat Care. 2008;25:298-308.

31.

Daut RL , Cleeland CS , Flanery RC Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain. 1983;17:197-210.

32.

Serlin R. , Mendoza T. , Nakamura YE , Edwards KR , Cleeland C. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain. 1995;61: 277-284.

33.

Stein KD , Denniston M. , Baker F. , et al. Validation of a modified Rotterdam Symptom Checklist for use with cancer patients in the United States. J Pain Symptom Manage. 2003; 26:975-989.

34.

Baker F. , Curbow B. , Wingard JR Role retention and quality of life of bone marrow transplant survivors. Soc Sci Med. 1991;32(6):697-704.

35.

Baker F. , Curbow B. , Wingard JR Development of the satisfaction with life domains scale for cancer. J Psychosoc Oncol. 1992;10(3):75-90.

36.

Baker F. , Denniston M. , Hann DM , Gesme DH , Reding D. , Kennedy J. Factor structure and concurrent validity of the satisfaction with life domains scale for cancer (SLDS-C). J Psychosoc Oncol. 2007;25:1-17.

37.

McNair D. , Lorr M. , Droppleman LF EITS Manual for Profile of Mood States. San Diego, CA: Education and Industrial Training Service , 1971.

38.

Shacham S. A shortened version of the Profile of Mood States. J Pers Assess. 1983;47:305-396.

39.

Curran S. , Andrykowski M. , Studts J. Short form of the Profile of Mood States (POMS-SF): psychometric information . Psychol Assess. 1995;7:80-83.

40.

Baker F. , Denniston M. , Zabora J. , Polland A. , Dudley W. A POMS short form for cancer patients: psychometric and structural evaluation . Psychooncology. 2002;11:273-281.

41.

Hann DM , Baker F. , Roberts CS , et al. Use of complementary therapies among breast and prostate cancer patients during treatment: a multisite study. Integr Cancer Ther. 2005;4: 294-300.

42.

Faily J. , Oneschuk D. Acupuncture in palliative care. Support Care Cancer. 2007;15:1003-1007.

43.

Mansky PJ , Wallerstedt DB Complementary medicine in palliative care and cancer symptom management. Cancer J. 2006;12:425-431.

44.

Kaptchuk TJ , Stason WB , Davis RB , et al. Sham device v inert pill: randomised controlled trial of two placebo treatments. BMJ. 2006;332:391-397.

45.

Braunholtz DA , Edwards SJ , Lilford RJ Are randomized clinical trials good for us (in the short term)? Evidence for a "trial effect." J Clin Epidemiol. 2001;54:217-224.